Pages that link to "Q33609474"
Jump to navigation
Jump to search
The following pages link to Microarray analysis reveals differential expression of benign and malignant pheochromocytoma (Q33609474):
Displaying 16 items.
- Pheochromocytoma: implications in tumorigenesis and the actual management (Q27024128) (← links)
- MicroRNA expression profiling in benign (sporadic and hereditary) and recurring adrenal pheochromocytomas. (Q34136208) (← links)
- Differential expression of estrogen receptor beta isoforms in prostate cancer through interplay between transcriptional and translational regulation (Q35056593) (← links)
- Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status (Q36024376) (← links)
- Copy number variations alter methylation and parallel IGF2 overexpression in adrenal tumors (Q36210460) (← links)
- Combined inhibition of mTORC1 and mTORC2 signaling pathways is a promising therapeutic option in inhibiting pheochromocytoma tumor growth: in vitro and in vivo studies in female athymic nude mice (Q36542866) (← links)
- Molecular and therapeutic advances in the diagnosis and management of malignant pheochromocytomas and paragangliomas (Q36804496) (← links)
- Role of hypoxia and HIF2α in development of the sympathoadrenal cell lineage and chromaffin cell tumors with distinct catecholamine phenotypic features (Q37202015) (← links)
- Phenylethanolamine N-methyltransferase downregulation is associated with malignant pheochromocytoma/paraganglioma (Q37269244) (← links)
- Pheochromocytomas and paragangliomas: assessment of malignant potential (Q37950920) (← links)
- Malignant pheochromocytomas and paragangliomas: a diagnostic challenge (Q37962361) (← links)
- Diagnostic tests and biomarkers for pheochromocytoma and extra-adrenal paraganglioma: from routine laboratory methods to disease stratification (Q37969708) (← links)
- From transcriptional profiling to tumor biology in pheochromocytoma and paraganglioma (Q37983021) (← links)
- Gene expression profiles of phaeochromocytomas with ERBB2 overexpression reveal a new molecular mechanism tumourigenicity (Q38497926) (← links)
- The VHL gene is epigenetically inactivated in pheochromocytomas and abdominal paragangliomas (Q41975304) (← links)
- Systemic surfaceome profiling identifies target antigens for immune-based therapy in subtypes of advanced prostate cancer. (Q52568663) (← links)